https://www.selleckchem.com/pr....oducts/anisomycin.ht
Limited data are available for pediatric patients with coronavirus disease 2019 (COVID-19), especially with regard to disease management strategies. To assess the children with COVID-19. We conducted a retrospective review of the medical records of pediatric patients on March 11 and May 23, 2020. We evaluated 77 COVID-19 pediatric patients, of whom 45.5% were male, with a median age of 8 years (interquartile range [IQR] = 2-13), and 6.4% had underlying diseases. Patients were classified according to severity, with the percentages of